Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?

Cathy Crombie; W Burns; Christos Karapetis; R Lowenthal; Fred Kirsten; J Davidson; Fiona Abell; William Reece; Jose Iglesias; Paul De Souza

Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?

Cathy Crombie, W Burns, Christos Karapetis, R Lowenthal, Fred Kirsten, J Davidson, Fiona Abell, William Reece, Jose Iglesias, Paul De Souza

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	24-31
Number of pages	8
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	5
Issue number	1
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{a07cb2d5c8e345dbbb7b06b293395e32,

title = "Randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small-cell lung cancer: Is thrombocytopenia predictable?",

author = "Cathy Crombie and W Burns and Christos Karapetis and R Lowenthal and Fred Kirsten and J Davidson and Fiona Abell and William Reece and Jose Iglesias and {De Souza}, Paul",

year = "2009",

language = "English",

volume = "5",

pages = "24--31",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",